Impact of the M184V Resistance Mutation on Virological Efficacy and Durability of Lamivudine-Based Dual Antiretroviral Regimens as Maintenance Therapy in Individuals With Suppressed HIV-1 RNA: A Cohort Study

BACKGROUND: Dual therapy (DT) with boosted protease inhibitors (bPIs) plus lamivudine has been shown to be superior to bPI monotherapy in virologically suppressed patients despite previous selection of the lamivudine resistance M184V mutation. We compared the virological efficacy of lamivudine-based...

Descripción completa

Detalles Bibliográficos
Autores principales: Gagliardini, Roberta, Ciccullo, Arturo, Borghetti, Alberto, Maggiolo, Franco, Bartolozzi, Dario, Borghi, Vanni, Pecorari, Monica, Di Biagio, Antonio, Callegaro, Anna Paola, Bruzzone, Bianca, Saladini, Francesco, Paolucci, Stefania, Maserati, Renato, Zazzi, Maurizio, Di Giambenedetto, Simona, De Luca, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6016422/
https://www.ncbi.nlm.nih.gov/pubmed/29977967
http://dx.doi.org/10.1093/ofid/ofy113

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6016422/
https://www.ncbi.nlm.nih.gov/pubmed/29977967
http://dx.doi.org/10.1093/ofid/ofy113

Ejemplares similares